St Jude Medical Inc. (STJ): Today's Featured Health Services Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

St Jude Medical ( STJ) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.1%. By the end of trading, St Jude Medical fell 62 cents (-1.7%) to $36.39 on average volume. Throughout the day, 3.2 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.9 million shares. The stock ranged in price between $36.31-$38.34 after having opened the day at $37.20 as compared to the previous trading day's close of $37.01. Other companies within the Health Services industry that declined today were: Oculus Innovative ( OCLS), down 7.2%, SunLink Health Systems ( SSY), down 6.5%, BG Medicine ( BGMD), down 6.1%, and Cardica ( CRDC), down 5.7%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. St Jude Medical has a market cap of $11.36 billion and is part of the health care sector. The company has a P/E ratio of 15.4, below the S&P 500 P/E ratio of 17.7. Shares are up 7.5% year to date as of the close of trading on Friday. Currently there are 15 analysts that rate St Jude Medical a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, CombiMatrix Corporation ( CBMX), up 32.2%, Advocat ( AVCA), up 9.1%, CardioNet ( BEAT), up 8.9%, and Celsion Corporation ( CLSN), up 8.5%, were all gainers within the health services industry with Baxter International ( BAX) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.

null

More from Markets

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices